

A practical guide for providers on helping patients locate Azasite during the 2026 shortage. Five actionable steps, alternatives, and workflow tips.
When you prescribe Azasite (Azithromycin ophthalmic solution 1%) in 2026, there's a reasonable chance your patient will call back to say their pharmacy doesn't have it. The ongoing Azasite shortage means that writing the prescription is only half the job — helping patients actually fill it requires a proactive approach.
This guide provides five practical steps your practice can take to improve patient access to Azasite, along with alternative prescribing strategies and workflow tips to reduce the administrative burden on your team.
As of early 2026, Azasite remains on the FDA drug shortage list. Key facts:
The shortage is exacerbated by the erythromycin ophthalmic ointment shortage, which has redirected prescribing volume toward Azasite — a product with limited manufacturing capacity.
Understanding the patient experience helps frame your response:
The most impactful intervention is simple: check if a pharmacy near the patient has Azasite before they leave your office.
Use Medfinder for Providers to search real-time pharmacy inventory. This takes 30 seconds and can save the patient hours of frustration. If you find a pharmacy with stock, send the prescription directly there.
If your EHR allows pharmacy selection at the point of prescribing, take advantage of it. Rather than defaulting to the patient's usual pharmacy, e-prescribe to a pharmacy you know has Azasite in stock or is more likely to carry specialty medications.
Good candidates include:
Consider writing two prescriptions: one for Azasite and one for an alternative (such as Moxifloxacin or Tobramycin). Tell the patient: "Try to fill the Azasite first. If they don't have it, fill the backup." This prevents a delay in treatment while the patient searches.
For blepharitis and MGD patients, you might pair the Azasite prescription with a plan for oral Doxycycline or Azithromycin as the fallback, along with lid hygiene instructions.
Azasite's brand-only status means many insurance plans require prior authorization or step therapy. Getting ahead of this:
For cost-saving details to share with patients, direct them to our guide on saving money on Azasite.
Patients who understand the shortage are more resilient when faced with pharmacy stockouts. Consider providing:
Having alternative protocols ready reduces prescribing delays:
| Medication | Dosing | Generic Available | Approximate Cost |
|---|---|---|---|
| Moxifloxacin 0.5% | TID x 7 days | Yes | $15-$50 |
| Tobramycin 0.3% | Q4-6h x 7 days | Yes | $10-$30 |
| Besifloxacin 0.6% | TID x 7 days | No | $200-$300 |
| Polymyxin B/Trimethoprim | Q3h x 7-10 days | Yes | $10-$25 |
| Approach | Details | Approximate Cost |
|---|---|---|
| Oral Doxycycline | 50-100 mg daily, 4-12 weeks | Under $20 (generic) |
| Oral Azithromycin | 500 mg day 1, 250 mg days 2-4 or pulsed | Under $15 (generic) |
| Lid hygiene + warm compresses | Daily, ongoing | $5-$15 (OTC supplies) |
| IPL therapy | In-office, series of 4 treatments | $200-$400 per session |
The Azasite shortage adds friction to prescribing, but a little proactive effort goes a long way. Checking availability before the patient leaves, having backup prescriptions ready, and educating patients about the shortage can transform a frustrating experience into a manageable one.
Tools like Medfinder for Providers are designed to make this process as painless as possible — for both your staff and your patients.
For the broader provider perspective on this shortage, see our companion briefing: Azasite shortage: what providers need to know in 2026. For the provider's guide to helping patients save money, see how to help patients save money on Azasite.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.